Phase II study of Gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group report

Authors

A. L. Angiolillo
J. Whitlock
Z. Chen
M. Krailo
G. Reaman

Document Type

Journal Article

Publication Date

2006

Journal

Pediatric Blood & Cancer

Volume

46

Issue

2

Inclusive Pages

193-197

APA Citation

Angiolillo, A., Whitlock, J., Chen, Z., Krailo, M., & Reaman, G. (2006). Phase II study of Gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group report. Pediatric Blood & Cancer, 46 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/4382